GRIFOLS S A/S (NASDAQ:GRFS) Upgraded at BidaskClub

Share on StockTwits

BidaskClub upgraded shares of GRIFOLS S A/S (NASDAQ:GRFS) from a buy rating to a strong-buy rating in a research report released on Saturday morning, BidAskClub reports.

A number of other analysts have also recently weighed in on GRFS. Zacks Investment Research raised GRIFOLS S A/S from a sell rating to a hold rating in a research report on Wednesday, July 24th. JPMorgan Chase & Co. raised GRIFOLS S A/S from a neutral rating to an overweight rating and raised their price objective for the stock from $21.00 to $22.50 in a research report on Thursday, June 27th. Finally, ValuEngine cut GRIFOLS S A/S from a hold rating to a sell rating in a research report on Thursday, August 1st. Three research analysts have rated the stock with a sell rating, three have assigned a hold rating, one has issued a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of Hold and an average target price of $20.75.

GRIFOLS S A/S stock opened at $21.72 on Friday. The company has a debt-to-equity ratio of 1.38, a current ratio of 2.68 and a quick ratio of 0.95. The firm has a market cap of $15.32 billion, a PE ratio of 19.37, a price-to-earnings-growth ratio of 1.34 and a beta of 1.11. GRIFOLS S A/S has a 1-year low of $17.42 and a 1-year high of $23.03. The stock has a fifty day simple moving average of $21.46.

GRIFOLS S A/S (NASDAQ:GRFS) last posted its quarterly earnings data on Tuesday, May 7th. The biotechnology company reported $0.25 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.25. The firm had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.29 billion. GRIFOLS S A/S had a return on equity of 14.38% and a net margin of 11.82%. As a group, equities research analysts forecast that GRIFOLS S A/S will post 1.26 EPS for the current year.

A number of institutional investors and hedge funds have recently modified their holdings of the business. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. lifted its position in GRIFOLS S A/S by 9.1% during the 1st quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 6,296 shares of the biotechnology company’s stock worth $127,000 after acquiring an additional 526 shares during the period. Wetherby Asset Management Inc. lifted its position in GRIFOLS S A/S by 5.5% during the 2nd quarter. Wetherby Asset Management Inc. now owns 16,189 shares of the biotechnology company’s stock worth $342,000 after acquiring an additional 849 shares during the period. Advisors Asset Management Inc. lifted its position in GRIFOLS S A/S by 40.8% during the 1st quarter. Advisors Asset Management Inc. now owns 5,108 shares of the biotechnology company’s stock worth $103,000 after acquiring an additional 1,479 shares during the period. Lenox Wealth Management Inc. lifted its position in GRIFOLS S A/S by 0.7% during the 1st quarter. Lenox Wealth Management Inc. now owns 236,947 shares of the biotechnology company’s stock worth $4,765,000 after acquiring an additional 1,652 shares during the period. Finally, Bank of Montreal Can lifted its position in GRIFOLS S A/S by 2.3% during the 1st quarter. Bank of Montreal Can now owns 89,850 shares of the biotechnology company’s stock worth $1,807,000 after acquiring an additional 2,017 shares during the period. 19.01% of the stock is owned by institutional investors.

About GRIFOLS S A/S

Grifols, SA, a specialty pharmaceutical company, develops, manufactures, and distributes a range of biological medicines on plasma derived proteins worldwide. The company operates through five segments: Bioscience, Diagnostic, Hospital, Bio Supplies, and Others. The Bioscience segment manufactures plasma derivatives for therapeutic use; and sells and distributes end products.

See Also: What is the Fibonacci sequence?

Analyst Recommendations for GRIFOLS S A/S (NASDAQ:GRFS)

Receive News & Ratings for GRIFOLS S A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GRIFOLS S A/S and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Sabre Corp  Shares Bought by Cpwm LLC
Sabre Corp Shares Bought by Cpwm LLC
Research Analysts’ New Coverage for August, 19th
Research Analysts’ New Coverage for August, 19th
Equities Research Analysts’ Price Target Changes for August, 19th
Equities Research Analysts’ Price Target Changes for August, 19th
Stock Analysts’ Updated EPS Estimates for August, 19th
Stock Analysts’ Updated EPS Estimates for August, 19th
Microchip Technology Inc.  Declares Quarterly Dividend of $0.37
Microchip Technology Inc. Declares Quarterly Dividend of $0.37
Cedar Capital LLC Increases Stake in ISHARES TR/3-7 YR TREAS BD ETF
Cedar Capital LLC Increases Stake in ISHARES TR/3-7 YR TREAS BD ETF


© 2006-2019 Ticker Report